Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Oculis Holding $40.25 million debut equity offering
The shares are listed on the Nasdaq Global Market
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Black Spade Acquisition $23 billion combination with VinFast
We are advising Black Spade on its de-SPAC transaction
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction
Josh Harris acquisition of Washington Commanders
We are advising the partnership led by Josh Harris on the transaction
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Crestview strategic investment in The Gersh Agency
We advised Crestview Partners on the transaction